Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01688765 · ClinicalTrials.gov registry record

Longitudinal Multimodal Neuroimaging Studies in Patients With First Episode Psychosis

A clinical trial of Psychotic Disorders, sponsored by Mclean Hospital.

Completed
Registry status
187
Enrollment target
1
Study location

NCT01688765: Completed study of Psychotic Disorders, sponsored by Mclean Hospital.

NCT01688765 is a study of Psychotic Disorders that has completed, run by Mclean Hospital. The registered enrollment target is 187 participants, below the 247-participant average among 22 other Psychotic Disorders trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01688765, a study of Psychotic Disorders, has completed, sponsored by Mclean Hospital.

COMPLETED
Registry status
187 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to investigate the structural, functional and chemical brain abnormalities in patients with first episode psychosis and assess the evolution of these abnormalities during the course of the disease.

Conditions Studied

Interventions

  • OTHER Observational

Study Locations (1)

Massachusetts

  • McLean Hospital - Belmont

Trial Details

FieldValue
Enrollment Target 187 participants
Start Date 2012-10-17
Est. Completion 2022-09-23
Mclean Hospital

140 total trials

What the finished NCT01688765 record still lists

NCT01688765 is an observational study that tracks outcomes without assigning an intervention. The registered 187 participants enrollment target is mid-sized for trials with a published cap, below the 247-participant average among 22 other Psychotic Disorders trials with a reported enrollment target (24% lower).

The record links to 1 condition, with Psychotic Disorders appearing as the primary indexed condition, and to 1 intervention - of which Observational is the first listed.

NCT01688765 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01688765 about?

NCT01688765 is a clinical study titled "Longitudinal Multimodal Neuroimaging Studies in Patients With First Episode Psychosis". The purpose of this study is to investigate the structural, functional and chemical brain abnormalities in patients with first episode psychosis and assess the evolution of these abnormalities during the course of the disease.

What is the current status of trial NCT01688765?

This trial is currently completed. The enrollment target is 187 participants. The study started on 2012-10-17. Estimated completion is 2022-09-23.

What conditions does trial NCT01688765 study?

This clinical trial studies the following conditions: Psychotic Disorders.

What interventions are being tested in trial NCT01688765?

The interventions under investigation include: Observational (OTHER).

Who is sponsoring clinical trial NCT01688765?

This trial is sponsored by Mclean Hospital, which has 140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01688765 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Psychotic Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01688765's enrollment target sits among peer trials

187 8th of 22 higher than 15 of 22 other Psychotic Disorders trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Psychotic Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06153251 · 187 participants · Phase 1

    A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma

  • NCT06254898 · 187 participants · NA

    Use of Incentives for Stressful Medical Procedures

  • NCT07062237 · 187 participants · NA

    A Randomized Clinical Trial Comparing Embryo Euploidy Rates Following Ultrashort Versus Standard Abstinence

  • NCT07217574 · 187 participants

    Program in Oncology for Tribal Health Systems.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01688765, the US trial registry maintained by the National Library of Medicine. NCT01688765 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.